18 results
8-K
EX-99.1
ARDX
Ardelyx Inc
22 Feb 24
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:04pm
of pediatric hyperphosphatemia.
The company had a significant presence at the American Society of Nephrology Kidney Week 2023 meeting in Philadelphia
8-K
EX-99.1
ARDX
Ardelyx Inc
31 Oct 23
Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U.S. IBSRELA® Net Sales Revenue Guidance
7:02am
North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, which took place in San Diego, California from October 4-7
8-K
EX-99.1
ARDX
Ardelyx Inc
3 Nov 22
Ardelyx Reports Third Quarter 2022 Financial
4:07pm
agreement.
Earlier today, the company presented two poster presentations at the American Society of Nephrology (ASN) Meeting, with a third poster
8-K
EX-99.1
ARDX
Ardelyx Inc
12 Nov 21
Ardelyx Reports Third Quarter 2021 Financial Results
8:05am
, 2021.
Recent Business Events
The company presented four posters at the American Society of Nephrology Kidney Week 2021 (ASN Kidney Week), which took … in the American Society of Nephrology Journal, Kidney 360. The publication highlights a clinically meaningful reduction in mean serum phosphorus from
8-K
EX-99.1
cr67g9
6 Mar 20
Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results
4:03pm
8-K
EX-99.1
lz3d86vlydfu z79phr
7 May 19
Ardelyx Reports First Quarter 2019 Financial Results and Recent Business Highlights
4:04pm
8-K
EX-99.1
0inx0xfr
7 Nov 18
Ardelyx Reports Third Quarter 2018 Financial Results and Recent Highlights
12:00am
10-K
podez0w541f5y9dlb8vl
5 Mar 15
Annual report
12:00am
8-K
EX-99.1
ifimtgvy2nf0d
23 Oct 14
Ardelyx’s Tenapanor Selected for Oral and Poster Presentations at the American
12:00am
8-K
ii096zmaqz
23 Oct 14
Ardelyx’s Tenapanor Selected for Oral and Poster Presentations at the American
12:00am
424B4
3pwawxkwjieqf 9cg2cd
19 Jun 14
Prospectus supplement with pricing info
12:00am
S-1/A
4a0qwgc65xoht95hw9nb
5 Jun 14
IPO registration (amended)
12:00am
- Prev
- 1
- Next